Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Dab2 protein is crucial for hair follicle stem cell renewal and preventing early aging.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

PDCD4 is important for controlling skin cell growth and healing.

A woman's hair turned white after taking a cancer drug called dasatinib.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

PTH-CBD agonists may help regrow hair after chemotherapy.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

MEF2C is crucial for normal hair cycle progression.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Erlotinib can cause hair loss as a side effect.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.